CTRI/2024/06/068254招募中4 期
A prospective, interventional, randomised, two-arm, single centre study to evaluate the effect of ten-on-ten syrup on children with attention deficit hyperactivity disorder (ADHD). - NI
Herba Neuva Implex Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children aged between 6-12 years who are diagnosed with mild to moderate ADHD.
- •2. Children irrespective of gender, religion, socio-economic status.
- •3. Patient’s parent/legal guardian who is ready to sign Consent Form.
排除标准
- •1. Children less than 6 years and more than 12 years.
- •2. Children with Epilepsy and taking anti-epileptic medications.
- •3. Children with severe comorbid conditions like oppositional defiant disorder, conduct disorder, substance abuse, anxiety disorder.
- •4. History of hypersensitivity or food allergy to components of omega 3/6, ( fish like salmon, mackerel, tuna, sardines, shellfish or flaxseed oil, Nuts and seeds such as flaxseed, chia seeds, and walnuts), herbal supplements shall be elicited on medical history.
- •5. Children taking anticoagulant medications like warfarin or aspirin.
- •6. Children with chronic systemic disease or other major psychiatric disorders.
研究者
相似试验
招募中
不适用
To assess the effect of dietary supplement capsules compared to Placebo capsules on joint healthCTRI/2021/10/037187OmniActive Health Technologies
已完成
2 期
A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.CTRI/2020/11/029328Indus Biotech Limited118
尚未招募
不适用
To assess the effect of dietary supplement capsules compared toPlacebo capsules on joint healthCTRI/2020/07/026603OmniActive Health Technologies
尚未招募
2 期
A clinical study of Probiotic - Bacillus coagulans LBSC in the treatment of drug-induced constipation.CTRI/2021/08/035889Advanced Enzyme Technologies Ltd
进行中(未招募)
不适用
A pilot study to evaluate accuracy of a digital platform which validates early risk and severity of Non-alcoholic Fatty Liver Disease (NAFLD) and disease management approach in Indian NAFLD patientsCTRI/2022/05/042359IIT Bombay
